Literature DB >> 2472589

Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy).

R C Kleiner1, L V Najarian, S Schatten, D A Jabs, A Patz, H J Kaplan.   

Abstract

The authors observed three cases (6 eyes) of vaso-occlusive retinopathy associated with the lupus anticoagulant and the related antiphospholipid antibody anticardiolipin. The disease occurred in patients who had no definable autoimmune disease such as systemic lupus erythematosus (SLE) and was characterized by severe bilateral retinal vascular occlusion. There was profound visual loss from intraretinal ischemia as well as vitreous hemorrhage from preretinal neovascularization. Results of laboratory testing showed a prolonged partial thromboplastin time (PTT) in two patients, and the presence of the lupus anticoagulant in all. Treatment with panretinal photocoagulation appeared to stabilize the neovascularization. The role of systemic anticoagulation and immunosuppressive therapy is uncertain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472589     DOI: 10.1016/s0161-6420(89)32825-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

Authors:  F Y Demirci; R Küçükkaya; K Akarçay; N Kir; T Atamer; H Demirci; E Ongör
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Familial recurrent cranial nerve palsy.

Authors:  K C Golnik; N R Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 3.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

4.  Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy?

Authors:  R A Asherson
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

Review 5.  Coagulation abnormalities and cerebral infarction.

Authors:  M Greaves
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

6.  Pathogenetic mechanisms in combined cilioretinal artery and retinal vein occlusion: a reappraisal.

Authors:  P D Brazitikos; C J Pournaras; P Othenin-Girard; F X Borruat
Journal:  Int Ophthalmol       Date:  1993-10       Impact factor: 2.031

7.  Hypercoagulable states in patients with retinal venous occlusion.

Authors:  A M Abu El-Asrar; A G Abdel Gader; S Al-Amro; A K Al-Momen
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

Review 8.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

9.  Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.

Authors:  M S Cappell; T Simon; M Tiku
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

10.  Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion.

Authors:  Paola Ferrazzi; Pierpaolo Di Micco; Ilaria Quaglia; Lisa Simona Rossi; Alessandro Giacco Bellatorre; Giorgio Gaspari; Lidia Luciana Rota; Corrado Lodigiani
Journal:  Thromb J       Date:  2005-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.